No title
Background: Glioblastoma carries a dismal prognosis, with only a small proportion of patients surviving beyond five or ten years. Although the introduction of new oncological therapies has improved median overall survival among treated patients, their impact on long-term survival in population-based cohorts remains unclear. The primary aim of this study was to analyze temporal trends in long-term
